Lale Özcan

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity”.

Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity

Journal of Clinical Investigation(2020)10.1172/jci135919

N/A

0DataRank · unranked

47 citations

Keiko Nakamura, Shana Gershbaum, Xiaobo Wang, Sherry Thomas, Marc Bessler +7 more

Targeting Soluble DPP-4 for Insulin Resistance: Origin Matters

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa902

N/A

0DataRank · unranked

3 citations

Devram Sampat Ghorpade, Ira Tabas, Lale Özcan

Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance

Molecular Metabolism(2021)10.1016/j.molmet.2021.101300

N/A

0DataRank · unranked

52 citations

Mayank Choubey, Sonal Patel, Harold A. Singer, Lale Özcan, Wen Dai

Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis

PLoS ONE(2021)10.1371/journal.pone.0246600

N/A

0DataRank · unranked

8 citations

Canan Kasikara, Arif Yurdagul, George Kuriakose, Brian K. Hubbard, Michael H. Serrano‐Wu +2 more

Allosteric MAPKAPK2 Inhibitors Improve Plaque Stability in Advanced Atherosclerosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.12.426264

N/A

0DataRank · unranked

2 citations

Canan Kasikara, Arif Yurdagul, George Kuriakose, Brian K. Hubbard, Michael H. Serrano‐Wu +2 more

Hepatocyte Rap1a contributes to obesity- and statin-associated hyperglycemia

Cell Reports(2022)10.1016/j.celrep.2022.111259

N/A

0DataRank · unranked

19 citations

Stefano Spolitu, John A. Zadroga, Amesh K. Sarecha, Lale Özcan, Yating Wang

Hepatocyte Rap1a Contributes To Obesity- and Statin-Associated Hyperglycemia

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.25.497009

N/A

0DataRank · unranked

1 citations

Stefano Spolitu, John A. Zadroga, Amesh K. Sarecha, Lale Özcan, Yating Wang

Rap1 Activation Protects Against Fatty Liver and Non-Alcoholic Steatohepatitis Development

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.24.563728

N/A

0DataRank · unranked

7 citations

Yating Wang, Lale Özcan, Heena Agarwal

Insulin sensitization by hepatic FoxO deletion is insufficient to lower atherosclerosis in mice

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.14.562366

N/A

0DataRank · unranked

1 citations

Michael Harris, Niroshan Shanmugarajah, Kendra Zhong, Lale Özcan, Gabrielle Fredman +2 more

Geranylgeranyl Isoprenoids and Hepatic Rap1a Regulate Basal and Statin-Induced Expression of PCSK9

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.23.563509

N/A

0DataRank · unranked

0 citations

Brea Tinsley, Stefano Spolitu, John A. Zadroga, Heena Agarwal, Amesh K. Sarecha +2 more

Geranylgeranyl isoprenoids and hepatic Rap1a regulate basal and statin-induced expression of PCSK9

Journal of Lipid Research(2024)10.1016/j.jlr.2024.100515

N/A

0DataRank · unranked

9 citations

Brea Tinsley, Stefano Spolitu, John A. Zadroga, Heena Agarwal, Amesh K. Sarecha +2 more

RAP1A suppresses hepatic steatosis by regulating amino acid-mediated mTORC1 activation

JHEP Reports(2024)10.1016/j.jhepr.2024.101303

N/A

0DataRank · unranked

4 citations

Yating Wang, Brea Tinsley, Xiaobo Wang, Lale Özcan, Heena Agarwal